>
Neovasc Inc logo

NVCN - Neovasc Inc Share Price

$0.745 -0.0  -2.0%

Last Trade - 2:44pm

Sector
Healthcare
Size
Micro Cap
Market Cap £36.9m
Enterprise Value £-2.07m
Revenue £1.61m
Position in Universe 6055th / 7256
Bullish
Bearish
Unlock NVCN Revenue
Momentum
Relative Strength (%)
1m -0.13%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -70.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
9.93 9.51 5.39 1.75 2.09 1.96 2.30 2.50 -27.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2021, Neovasc Increvenues increased 33% to $1.1M. Net loss decreased 20% to$11.2M. Revenues reflect Europe segment increase of 31% to$1M, Rest of the World segment increase of 52% to $80K.Lower net loss reflects Unrealized gain on derivativeliability increase from $3.5M to $15.3M (income), Cashbased employee expenses decrease of 29% to $2.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NVCN Revenue Unlock NVCN Revenue

Net Income

NVCN Net Income Unlock NVCN Revenue

Normalised EPS

NVCN Normalised EPS Unlock NVCN Revenue

PE Ratio Range

NVCN PE Ratio Range Unlock NVCN Revenue

Dividend Yield Range

NVCN Dividend Yield Range Unlock NVCN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
NVCN EPS Forecasts Unlock NVCN Revenue
Profile Summary

Neovasc Inc. is a Canada-based medical device company. The Company is developing, manufacturing and marketing products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, and Tiara (TM) for the transcatheter treatment of mitral valve disease.

Directors
Last Annual December 31st, 2020
Last Interim June 30th, 2021
Incorporated April 19, 2002
Public Since May 23, 2001
No. of Shareholders: n/a
No. of Employees: 71
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market (Dual Listing)
Shares in Issue 67,584,412
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NVCN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NVCN
Upcoming Events for NVCN
Wednesday 3rd November, 2021 Estimate
Q3 2021 Neovasc Inc Earnings Release
Wednesday 3rd November, 2021 Estimate
Q3 2021 Neovasc Inc Earnings Release
Wednesday 9th March, 2022 Estimate
Q4 2021 Neovasc Inc Earnings Release
Wednesday 9th March, 2022 Estimate
Q4 2021 Neovasc Inc Earnings Release
Frequently Asked Questions for Neovasc Inc
What is the Neovasc Inc share price?

As of 2:44pm, shares in Neovasc Inc are trading at $0.745, giving the company a market capitalisation of £36.9m. This share price information is delayed by 15 minutes.

How has the Neovasc Inc share price performed this year?

Shares in Neovasc Inc are currently trading at $0.745 and the price has moved by -69.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Neovasc Inc price has moved by -76.89% over the past year.

What are the analyst and broker recommendations for Neovasc Inc?

Of the analysts with advisory recommendations for Neovasc Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Neovasc Inc is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Neovasc Inc next release its financial results?

Neovasc Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Neovasc Inc dividend yield?

Neovasc Inc does not currently pay a dividend.

Does Neovasc Inc pay a dividend?

Neovasc Inc does not currently pay a dividend.

When does Neovasc Inc next pay dividends?

Neovasc Inc does not currently pay a dividend.

How do I buy Neovasc Inc shares?

To buy shares in Neovasc Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Neovasc Inc?

Shares in Neovasc Inc are currently trading at $0.745, giving the company a market capitalisation of £36.9m.

Where are Neovasc Inc shares listed? Where are Neovasc Inc shares listed?

Here are the trading details for Neovasc Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: NVCN
What kind of share is Neovasc Inc?

Based on an overall assessment of its quality, value and momentum, Neovasc Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Neovasc Inc share price forecast 2021?

Shares in Neovasc Inc are currently priced at $0.745. At that level they are trading at 0.112% discount to the analyst consensus target price of 0.00.

Analysts covering Neovasc Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.36 for the next financial year.

How can I tell whether the Neovasc Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neovasc Inc. Over the past six months, the relative strength of its shares against the market has been -20.88%. At the current price of $0.745, shares in Neovasc Inc are trading at -23.84% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Neovasc Inc PE Ratio?

We were not able to find PE ratio data for Neovasc Inc.

Who are the key directors of Neovasc Inc?

Neovasc Inc's management team is headed by:

Paul Geyer - IND
Alexei Marko - DRC
Douglas Janzen - IND
Christopher Clark - CFO
Steven Rubin - NEC
Fred Colen - PRE
Norman Radow - IND
Bill Little - COO
Lisa Becker - VPR
Sarah Gallagher - VPR
Who are the major shareholders of Neovasc Inc?

Here are the top five shareholders of Neovasc Inc based on the size of their shareholding:

Strul Medical Group, L.L.C. Corporation
Percentage owned: 9.2% (6.22m shares)
Heights Capital Management, Inc. Investment Advisor
Percentage owned: 5.92% (4.00m shares)
Intracoastal Capital, L.L.C. Corporation
Percentage owned: 3.57% (2.41m shares)
Colen (Fredericus A) Individual Investor
Percentage owned: 3.04% (2.06m shares)
Rubin (Steven D) Individual Investor
Percentage owned: 2.91% (1.97m shares)
Similar to NVCN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.